Hopkins Laboratories, Inc. has developed a new diabetes drug called Sugardown.
Hopkins Laboratories, Inc. has developed a new diabetes drug called Sugardown. This drug is a first-in-class molecule and was submitted for an expedited review by the Food and Drug Administration. Trials demonstrated modest efficacy at lowering blood glucose. Additionally, pre-clinical testing suggested a possible excess of kidney tumors in mice and rats. Good news! […]